FDA approves Pfizer's leukemia drug
(Reuters) - The U.S. Food and Drug Administration (FDA) on Friday approved Pfizer Inc's drug, Mylotarg, for certain patients with acute myeloid leukemia (AML).
Source: Reuters: Health - Category: Consumer Health News Tags: healthNews Source Type: news
More News: Acute Leukemia | Acute Myeloid Leukemia | Food and Drug Administration (FDA) | Health | Leukemia | Pfizer